C-Bridge Capital Partners LLC - Company Review
C-Bridge Capital Partners LLC - Company ReviewSummary
C-Bridge Capital Partners LLC (C-Bridge Capital), a subsidiary of Island Capital Group, LLC is a provider of advisory services. It facilitates cross-border investments and asset formation in the US, China and Israel. The company spans its expertise in business model formulation; international business expansion; and strategic negotiations among others. C-Bridge Capital assists, consult and co-invest in commercial properties in the US. The company establishes strategic alliances and joint ventures at the individual, corporate and government levels to expand real estate business platforms in the Asia Pacific region. C-Bridge Capital is headquartered in New York, the US.
This comprehensive company report of C-Bridge Capital Partners LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.